Efficacy of contraceptive methods: A review of the literature

Republished from: The European Journal of Contraception and Reproductive Health Care, 2010;15:1–3

[1]  I. Milsom,et al.  Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. , 2006, Contraception.

[2]  J. Schnitker,et al.  Clinical experience with a modern low-dose oral contraceptive in almost 100,000 users. , 1991, Contraception.

[3]  K. Barnhart,et al.  Contraceptive Efficacy of a Novel Spermicidal Microbicide Used With a Diaphragm: A Randomized Controlled Trial , 2007, Obstetrics and gynecology.

[4]  A. Faúndes,et al.  A Latin American experience with levonorgestrel IUD. , 1993, Annals of medicine.

[5]  A. Fisher,et al.  Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. , 2001, JAMA.

[6]  C. Petta,et al.  Clinical evaluation of the TCu 380A IUD at six Latin American centers. , 1994, Contraception.

[7]  V. Clark,et al.  Evaluation of the efficacy of a nonlatex condom: results from a randomized, controlled clinical trial. , 2003, Perspectives on sexual and reproductive health.

[8]  Wilson Jc.  A New Zealand randomized comparative study of three IUDs (Nova-T, MLCu375, MLAgCu250): 1-, 2- and 3-year results. , 1992 .

[9]  F. Weber-Diehl,et al.  Triphasic combination of ethinyl estradiol and gestodene. Long-term clinical trial. , 1992, Contraception.

[10]  M. David,et al.  Clinical performance of the TCu 380A and TCu 220C IUDs in four developing country family planning clinics. , 1994, Contraception.

[11]  Z. Gu.  Comparison of two uterine cavity-shaped IUDs. , 1992, Contraception.

[12]  J. Garza-flores,et al.  Introduction of cyclofem once-a-month injectable contraceptive in Mexico. , 1998, Contraception.

[13]  I. Sivin,et al.  Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR). , 1994, Fertility and sterility.

[14]  I. Sivin,et al.  A 5‐Year Evaluation of NORPLANT Contraceptive Implants in China , 1994, Obstetrics and gynecology.

[15]  D. Shoupe.  Multicenter Randomized Comparative Trial of Two Low‐Dose Triphasic Combined Oral Contraceptives Containing Desogestrel or Norethindrone , 1994, Obstetrics and Gynecology.

[16]  D. Mishell,et al.  Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS. , 1991, Contraception.

[17]  T. R. Dunson,et al.  A comparative study of 35 mcg and 50 mcg combined oral contraceptives: results from a multicenter clinical trial. , 1991, Contraception.

[18]  J. Hanker,et al.  A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel over six treatment cycles , 1997 .

[19]  D. Mishell,et al.  Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic. , 1998, Contraception.

[20]  D. Mishell,et al.  Performance of the TCu380A and Cu-Fix IUDs in an international randomized trail. , 1996, Contraception.

[21]  J. J. Etchepareborda,et al.  A multicentred, two-year, phase III clinical trial of norethisterone enanthate 50 mg plus estradiol valerate 5 mg as a monthly injectable contraceptive. , 1991, Contraception.

[22]  Susheela Singh,et al.  Estimates of contraceptive failure from the 2002 National Survey of Family Growth. , 2008, Contraception.

[23]  J. Tripp,et al.  Clinical performance of the levonorgestrel intrauterine system in routine use by the UK Family Planning and Reproductive Health Research Network*: 5-year report , 2002, Journal of Family Planning and Reproductive Health Care.

[24]  T. Rabe,et al.  The efficacy and tolerability of norgestimate/ethinyl estradiol (250 μg of norgestimate/35 μg of ethinyl estradiol): Results of an open, multicenter study of 59,701 women , 1992 .

[25]  I. Wahyudi,et al.  A comparative clinical trial of the TCu 380A, Lippes Loop D and Multiload Cu 375 IUDs in Indonesia. , 1991, Contraception.

[26]  P. Darney.  Safety and efficacy of a triphasic oral contraceptive containing desogestrel: results of three multicenter trials. , 1993, Contraception.

[27]  D. Sokal,et al.  Two randomized controlled trials comparing the Hulka and Filshie Clips for tubal sterilization. , 2000, Contraception.

[28]  S. Rahman,et al.  A five-year clinical evaluation of Norplant contraceptive subdermal implants in Bangladeshi acceptors. , 1993, Contraception.

[29]  E. Godehardt,et al.  Retrospective Clinical Trial of Contraceptive Effectiveness of the Electronic Fertility Indicator Ladycomp/Babycomp , 1998, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[30]  A. Faúndes,et al.  Effectiveness of the diaphragm, used continuously, without spermicide. , 1993, Contraception.

[31]  I. Sivin,et al.  Effectiveness of Norplant implants through seven years: a large-scale study in China. , 1995, Contraception.

[32]  Irit Sinai,et al.  Efficacy of a new method of family planning: the Standard Days Method. , 2002, Contraception.

[33]  A. Fisher,et al.  Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20. , 2001, Contraception.

[34]  H. Bennink,et al.  A comparison of the inhibition of ovulation achieved by desogestrel 75 μg and levonorgestrel 30 μg daily , 1999 .

[35]  C. Gerlinger,et al.  Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrel , 2001 .

[36]  J. Trussell,et al.  Methodological pitfalls in the analysis of contraceptive failure. , 1991, Statistics in medicine.

[37]  A. Kaunitz.  Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial. , 2000, Contraception.

[38]  A. Fisher,et al.  Efficacy and Safety of a Transdermal Contraceptive System , 2001, Obstetrics and gynecology.

[39]  D. Apter,et al.  Efficacy, Cycle Control, and User Acceptability of a Novel Combined Contraceptive Vaginal Ring , 2002, Obstetrics and gynecology.

[40]  F. Skjeldestad,et al.  A randomized trial on the clinical performance of Nova T®380 and Gyne T®380 Slimline copper IUDs ☆ , 2007 .

[41]  M. Gatto,et al.  Multicenter, double-blind, comparative clinical study on the efficacy and acceptability of a monthly injectable contraceptive combination of 150 mg dihydroxyprogesterone acetophenide and 10 mg estradiol enanthate compared to a monthly injectable contraceptive combination of 90 mg dihydroxyprogestero , 1997, Contraception.

[42]  J. Toivonen,et al.  Protective Effect of Intrauterine Release of Levonorgestrel on Pelvic Infection: Three Years' Comparative Experience of Levonorgestrel- and Copper-Releasing Intrauterine Devices , 1991, Obstetrics and gynecology.

[43]  G. Farr,et al.  Contraceptive efficacy of the Copper T 380A and Copper T 200 intrauterine devices: results from a comparative clinical trial in six developing countries. , 1994, Contraception.

[44]  H. von Hertzen,et al.  Multicenter study of the Lactational Amenorrhea Method (LAM): I. Efficacy, duration, and implications for clinical application. , 1997, Contraception.

[45]  G. Stuart,et al.  Initiation of Oral Contraceptives Using a Quick Start Compared With a Conventional Start: A Randomized Controlled Trial , 2007, Obstetrics and gynecology.

[46]  M. Koskenvuo,et al.  Pregnancy during the use of levonorgestrel intrauterine system. , 2004, American journal of obstetrics and gynecology.

[47]  S. Nakajima,et al.  Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe). , 2007, Contraception.

[48]  D. Apter,et al.  Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. , 2001, Human reproduction.

[49]  C. Gerlinger,et al.  Recommendation for confidence interval and sample size calculation for the Pearl Index , 2003, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[50]  F. Martínez,et al.  Experience with GyneFIX insertions in Spain: favorable acceptance of the intrauterine contraceptive implant with some limitations. , 2002, Contraception.

[51]  I. Sivin,et al.  The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study. , 1998, Human reproduction.

[52]  J. Bringer,et al.  Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception. , 2005, European journal of obstetrics, gynecology, and reproductive biology.

[53]  J. Tripp,et al.  Clinical performance of the Nova T380® intrauterine device in routine use by the UK Family Planning and Reproductive Health Research Network*: 5-year report , 2002, Journal of Family Planning and Reproductive Health Care.

[54]  G. Sang,et al.  Clinical experience with triphasic oral contraceptive (Triquilar) in 527 women in China. , 1991, Contraception.

[55]  T. Zimmermann,et al.  Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in the Czech Republic. , 2002, Methods and findings in experimental and clinical pharmacology.

[56]  A. Fisher,et al.  The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy. , 2004, Contraception.

[57]  A. Kaunitz,et al.  Contraceptive efficacy and safety of DMPA-SC. , 2004, Contraception.

[58]  K. Nanda,et al.  Contraceptive Effectiveness of a Polyurethane Condom and a Latex Condom: A Randomized Controlled Trial , 2003, Obstetrics and gynecology.

[59]  A. Kaunitz,et al.  Comparative safety, efficacy, and cycle control of Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension) and Ortho-Novum 7/7/7 oral contraceptive (norethindrone/ethinyl estradiol triphasic). Lunelle Study Group. , 1999, Contraception.

[60]  Mohamed M. Ali,et al.  Periodic abstinence in developing countries: an assessment of failure rates and consequences. , 2004, Contraception.

[61]  J. J. Etchepareborda,et al.  Multicentred, phase III clinical trial of norethisterone enanthate 50 mg plus estradiol valerate 5 mg as a monthly injectable contraceptive; final three-year report. , 1994, Contraception.

[62]  S. Skouby,et al.  Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries , 2004, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[63]  L. Shulman.  Controlled trial with a monthly combination injectable contraceptive in the USA. , 2001, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[64]  N. R. de Melo,et al.  Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial. , 2005, Contraception.

[65]  A. Gauthier,et al.  Clinical evaluation of a new triphasic oral contraceptive: norgestimate and ethinyl estradiol , 1992, Acta obstetricia et gynecologica Scandinavica. Supplement.

[66]  D. Archer,et al.  A new low-dose monophasic combination oral contraceptive (Alesse™) with levonorgestrel 100 μg and ethinyl estradiol 20 μg , 1997 .

[67]  I. Sivin,et al.  Safety and Efficacy of Levonorgestrel Implant, Intrauterine Device, and Sterilization , 2001, Obstetrics and gynecology.

[68]  V. Odlind,et al.  Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. , 1994, Contraception.

[69]  M. Notelovitz.  Contraceptive efficacy and safety of a monophasic oral contraceptive containing 150 μg desogestrel and 30 μg ethinyl estradiol: United States clinical experience using a “Sunday start” approach * , 1995 .

[70]  V. Clark,et al.  Evaluation of the efficacy of a polyurethane condom: results from a randomized, controlled clinical trial. , 1999, Family planning perspectives.

[71]  C. Gerlinger,et al.  Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study. , 1999, Contraception.

[72]  L. Vázquez-Estrada,et al.  Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant , 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[73]  H. C. Coelingh Bennink,et al.  A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group. , 1999, Human reproduction.

[74]  J. Bonnar,et al.  Personal hormone monitoring for contraception. , 1999, The British journal of family planning.

[75]  H. Sangi-Haghpeykar,et al.  Experiences of Injectable Contraceptive Users in an Urban Setting , 1996, Obstetrics and gynecology.

[76]  L. Bahamondes,et al.  Comparison of the performances of TCu380A and TCu380S IUDs up to five years , 1999, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[77]  G. Constantine,et al.  Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results. , 2006, Contraception.

[78]  Sang Guo-wei,et al.  A multicentered clinical trial of the long-acting injectable contraceptive Depo Provera in Chinese women. , 2000, Contraception.

[79]  J. Trussell,et al.  Contraceptive efficacy of the diaphragm, the sponge and the cervical cap. , 1993, Family planning perspectives.

[80]  J. Andreas,et al.  Efficacy and safety of the new antiandrogenic oral contraceptive Belara. , 1998, Contraception.

[81]  D. Mishell,et al.  Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the copper T 380A IUD. , 1997, Contraception.

[82]  D. Weiner,et al.  A comparative study of the safety and efficacy of FemCap, a new vaginal barrier contraceptive, and the Ortho All-Flex diaphragm. The FemCap Investigators' Group. , 1999, Contraception.

[83]  L. Bahamondes,et al.  Introductory study of the once-a-month, injectable contraceptive Cyclofem in Brazil, Chile, Colombia, and Peru. , 1997, Contraception.

[84]  D. Mishell,et al.  Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. , 1990, Contraception.

[85]  R. Mukherjee,et al.  A comparative study of two low-dose combined oral contraceptives: results from a multicenter trial. , 1993, Contraception.

[86]  G. Farr,et al.  Twelve-month comparative multicenter study of the TCu 380A and ML 250 intrauterine devices in Bangkok, Thailand. , 1998, Contraception.

[87]  D. Sokal,et al.  Two randomized controlled trials comparing the tubal ring and filshie clip for tubal sterilization. , 2000, Fertility and sterility.

[88]  V. Brache,et al.  Four-year experience in a randomized study of the Gyne T∗ 380 slimline and the standard Gyne T∗ 380 intrauterine copper devices☆ , 1993 .

[89]  W. Olson,et al.  Comparative contraceptive efficacy and mechanism of action of the norgestimate‐containing triphasic oral contraceptive , 1992, Acta obstetricia et gynecologica Scandinavica. Supplement.

[90]  C. Bardin,et al.  Selection and performance of the levonorgestrel-releasing intrauterine system. , 1997, Acta obstetricia et gynecologica Scandinavica. Supplement.

[91]  T. Eskes,et al.  Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive , 2000, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[92]  I. Sivin,et al.  Two-year comparative trial of the Gyne T* 380 Slimline and Gyne T* 380 intrauterine copper devices. , 1991, Contraception.

[93]  D. Cibula,et al.  Women's contraceptive practices and sexual behaviour in Europe , 2008, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[94]  J. Xu,et al.  Billings natural family planning in Shanghai, China , 1994, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[95]  T. Zimmermann,et al.  Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in Poland. , 2002, Methods and findings in experimental and clinical pharmacology.

[96]  I. Sivin,et al.  A five-year evaluation of NORPLANT II implants in China. , 1994, Contraception.

[97]  T. Korver.  A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 μg/day or levonorgestrel 30 μg/day: Collaborative Study Group on the Desogestrel-containing Progestogen-only Pill , 1998 .

[98]  L. Grummer-Strawn,et al.  Contraceptive failure of the ovulation method of periodic abstinence. , 1990, Family planning perspectives.

[99]  M. Åkerlund,et al.  Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 μg desogestrel and either 30 μg or 20 μg ethinyl oestradiol , 1993 .

[100]  D. Mishell,et al.  Prolonged effectiveness of Norplant(R) capsule implants: a 7-year study. , 2000, Contraception.

[101]  U. Müller,et al.  A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene. , 1996, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[102]  M. Carey,et al.  Recruiting patients from a sexually transmitted disease clinic to sexual risk reduction workshops: are monetary incentives necessary? , 2005, Journal of public health management and practice : JPHMP.

[103]  S. Bassol,et al.  A multicenter comparative study on the efficacy, safety, and acceptability of the contraceptive subdermal implants Norplant and Norplant-II. , 1997, Contraception.

[104]  I. Sivin,et al.  Clinical performance of a new two-rod levonorgestrel contraceptive implant: a three-year randomized study with Norplant implants as controls. , 1997, Contraception.

[105]  P. D. De Silva,et al.  A multicenter comparative trial of triphasic and monophasic, low-dose combined oral contraceptives. , 1993, Contraception.

[106]  J. Foidart,et al.  Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone , 2000, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[107]  Rosalie Dominik,et al.  Understanding risk: a randomized controlled trial of communicating contraceptive effectiveness. , 2003, Obstetrics and gynecology.

[108]  L. Bahamondes,et al.  Long-term evaluation of the clinical performance of the TCu200B and the TCu380A in Campinas, Brazil , 1992, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[109]  R. Turck,et al.  Large observational trial of a new low-dose oral contraceptive containing 20 μg ethinylestradiol and 100 μg levonorgestrel (Miranovar`) in Germany , 1999 .

[110]  N. Benda,et al.  Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone , 2004 .

[111]  J. Schnitker,et al.  Clinical experience with a modern low-dose gestodene-containing oral contraceptive in adolescents , 1994, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[112]  S. Corson.  Efficacy and Clinical Profile of a New Oral Contraceptive Containing Norgestimate: U.S. Clinical Trials , 1990, Acta obstetricia et gynecologica Scandinavica. Supplement.

[113]  D. Portman,et al.  Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol. , 2006, Contraception.

[114]  Contraceptive failure rates in France: results from a population-based survey. , 2007 .

[115]  J. Trussell,et al.  The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. , 1996, American journal of obstetrics and gynecology.

[116]  L. Grummer-Strawn,et al.  Further analysis of contraceptive failure of the ovulation method. , 1991, American journal of obstetrics and gynecology.

[117]  I. Sivin,et al.  A randomized trial of the Gyne T 380 and Gyne T 380 Slimline Intrauterine Copper devices. , 1990, Contraception.

[118]  L. Kovács,et al.  Multicenter study in Hungary with a 30μg ethinylestradiol- and 150μg desogestrel-containing monophasic oral contraceptive , 1994 .

[119]  D. Archer,et al.  Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 μg levonorgestrel and 20 μg ethinyl estradiol (Alesse®) , 1999 .

[120]  D. Mishell,et al.  Levonorgestrel Capsule Implants in the United States: A 5‐Year Study , 1998, Obstetrics and gynecology.

[121]  E. O. Hassan,et al.  Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects. , 1999, Contraception.

[122]  D. Cibula,et al.  Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20μg and Drospirenone 3mg , 2006, Clinical drug investigation.

[123]  P. Lammers,et al.  Phase III clinical trial with a new oral contraceptive containing 150 μg desogestrel and 20 μg ethinylestradiol , 1991 .

[124]  Croxatto Hb.  Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant. , 2000 .

[125]  R. Ge,et al.  A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects. , 1995, Contraception.

[126]  Task Force on Long-acting Systemic Agents for Fertility Regulation.  Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna® and Cyclofem®) on lipid and lipoprotein metabolism , 1997 .

[127]  D. Archer,et al.  A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG). , 1997, Contraception.

[128]  Worldbankiudresearchgroup.  The TCu 380A IUD and the frameless IUD "the FlexiGard": interim three-year data from an international multicenter trial. UNDP, UNFPA, and WHO Special Programme of Research, Development and Research Training in Human Reproduction, World Bank: IUD Research Group. , 1995, Contraception.

[129]  G. Farr,et al.  Contraceptive efficacy of the Copper T380A and the Multiload Cu250 IUD in three developing countries , 1994, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[130]  A. Soejoenoes,et al.  Efficacy of three variations of periodic abstinence for family planning in Indonesia. , 1990, Studies in family planning.

[131]  D. Torgerson,et al.  Should we pay the patient? Review of financial incentives to enhance patient compliance , 1997, BMJ.